Document Detail

Fetal thrombotic vasculopathy is associated with thromboembolic events and adverse perinatal outcome but not with neurologic complications: A retrospective cohort study of 54 cases with a 3-year follow-up of children.
MedLine Citation:
PMID:  24862569     Owner:  NLM     Status:  Publisher    
OBJECTIVE: to test the hypothesis that placental fetal thrombotic vasculopathy (FTV) is associated with obstetric complications and predisposes the child to unfavorable outcomes.
METHODS: 54 placentas with FTV lesions and 100 placentas without FTV lesions were collected over a 5-year period at the Croix-Rousse Pathology Department. Clinical findings including maternal, fetal, neonatal condition and pediatric outcome up to three years were collected for each case and control observation. The statistical analyses were assessed with Wald's chi-square derived from conditional logistic regression modeling.
RESULTS: FTV was associated with a significantly higher frequency of obstetric complications: (pregnancy-induced hypertension (OR 3.620, CI 1.563-8.385), preeclampsia (OR 3.674, CI 1.500-8.998), emergency delivery procedures (OR 3.727, CI 1.477-9.403), cesarean sections (OR 2.684, CI 1.016-7.088)), poor fetal condition (intrauterine growth restriction (IUGR) (OR 5.440, CI 2.007-14.748), nonreassuring fetal heart tracing (OR 6.062, CI 2.280-16.115), difficulties in immediate ex utero adaptation (OR 3.416, CI 1.087-10.732)) and perinatal or early childhood demise (OR 3.043, CI 1.327-6.978). On pathological examination, FTV was associated with marginal cord insertion (OR 3.492, CI 1.350-9.035), cord stricture and hypercoiled cord (OR 3.936, CI 1.209-12.813). Thromboembolic events were significantly more frequent in cases with FTV (OR 2.154, CI 1.032-5.622). Neurological complications within the first 3 years of life were also more frequent in the FTV group compared to the control group, but this association was not statistically significant.
CONCLUSIONS: FTV is associated with maternal complications, pathological findings in the placenta, especially gross cord abnormalities, IUGR, and poor perinatal or early childhood outcome. It may also predispose children to somatic thromboembolic events.
L Lepais; L Gaillot-Durand; F Boutitie; F Lebreton; R Buffin; C Huissoud; J Massardier; L Guibaud; M Devouassoux-Shisheboran; F Allias
Related Documents :
24348019 - Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile pa...
24485199 - Fetal demise and associated factors following umbilical cord prolapse in mulago hospita...
24982809 - The importance of a late first trimester placental sonogram in patients at risk of abno...
24667289 - Considerations in using registry and health plan data for studying pregnancy in rheumat...
23573319 - The effect of accompanying dominant follicle development/ovulation on the outcomes of f...
23943699 - Emergency cerclage placement in multifetal pregnancies with a dilated cervix and expose...
2300359 - Measuring the number of lamellar body particles in amniotic fluid.
22534329 - A metabolomic approach identifies differences in maternal serum in third trimester preg...
16381989 - Lack of association between thyroid autoantibodies and parity in a population study arg...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-5-10
Journal Detail:
Title:  Placenta     Volume:  -     ISSN:  1532-3102     ISO Abbreviation:  Placenta     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-5-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand express...
Next Document:  Organellophagy: Eliminating cellular building blocks via selective autophagy.